title: Assessing the external validity of a randomized controlled trial of anthelminthics in mothers and their children in Entebbe, Uganda.
abstract: BACKGROUND
  The 'external validity' of randomized controlled trials is an important measure of quality, but is often not formally assessed. Trials concerning mass drug administration for helminth control are likely to guide public health policy and careful interpretation of their context is needed. We aimed to determine how representative participants in one such trial were of their community. We explore implications for trial interpretation and resulting public health recommendations.
  
  
  METHODS
  The trial assessed was the Entebbe Mother and Baby Study (EMaBS), a trial of anthelminthic treatment during pregnancy and early childhood. In a novel approach for assessing external validity, we conducted a two-stage cluster sample community survey within the trial catchment area and compared characteristics of potentially-eligible community children with characteristics of children participating in the trial.
  
  
  RESULTS
  A total of 173 children aged three to five-years-old were surveyed from 480 households. Of children surveyed, we estimated that mothers of 60% would have been eligible for recruitment, and of these, 31% had actually been enrolled. Children surveyed were compared to 199 trial children in the same age group reviewed at annual trial visits during the same time period. There were significant differences in ethnicity between the trial participants and the community children, and in socioeconomic status, with those in the trial having, on average, more educated parents and higher maternal employment. Trial children were less likely to have barefoot exposure and more likely to use insecticide-treated bed nets. There were no significant differences in numbers of reported illness events over the last year.
  
  
  CONCLUSIONS
  The trial had not enrolled all eligible participants, and those enrolled were of higher socioeconomic status, and had lower risk of exposure to the parasitic infections targeted by the trial interventions. It is possible the trial may have underestimated the absolute effects of anthelminthic treatment during pregnancy and early childhood, although the fact that there were no differences in reported incidence of common infectious diseases (one of the primary outcomes of EMaBS) between the two groups provides reassurance. Concurrent community surveys may be an effective way to test the external validity of trials.
  ISRCTN32849447, registered 22 July 2005.
authors.affiliation: Department of Global Health, Division of Clinical Medicine, Brighton and Sussex Medical School, Falmer, Brighton BN1 9PX, UK. j.millard@bsms.ac.uk.
authors.forename: James D
authors.initials: JD
authors.lastname: Millard
authors.forename: Lawrence
authors.initials: L
authors.lastname: Muhangi
authors.forename: Moses
authors.initials: M
authors.lastname: Sewankambo
authors.forename: Juliet
authors.initials: J
authors.lastname: Ndibazza
authors.forename: Alison M
authors.initials: AM
authors.lastname: Elliott
authors.forename: Emily L
authors.initials: EL
authors.lastname: Webb
mesh_terms: D000871:Anthelmintics / Q000627:therapeutic use*; D002675:Child, Preschool; D005260:Female; D006801:Humans; D009035:Mothers; D018579:Patient Selection; D011247:Pregnancy; D016032:Randomized Controlled Trials as Topic; D012923:Social Class; D014454:Uganda
chemical_list: D000871:Anthelmintics
references.citation: Pediatr Allergy Immunol. 2011 May;22(3):305-12
references.pmid: 21255083
references.citation: BMC Pregnancy Childbirth. 2007 Oct 11;7:23
references.pmid: 17931422
references.citation: Surv Ophthalmol. 2007 May-Jun;52(3):266-78
references.pmid: 17472802
references.citation: Neurol Sci. 2006 Jun;27 Suppl 3:S228-30
references.pmid: 16752054
references.citation: Lancet. 2001 Mar 3;357(9257):724
references.pmid: 11247593
references.citation: NeuroRx. 2004 Jul;1(3):363-71
references.pmid: 15717039
references.citation: J Rheumatol. 2003 Jun;30(6):1138-46
references.pmid: 12784382
references.citation: Am Heart J. 2003 Aug;146(2):250-7
references.pmid: 12891192
references.citation: Heart. 2003 Mar;89(3):327-8
references.pmid: 12591845
references.citation: J Clin Epidemiol. 2007 Apr;60(4):330-5
references.pmid: 17346605
references.citation: Ann Intern Med. 2002 Jul 2;137(1):10-6
references.pmid: 12093240
references.citation: Chest. 2006 Jan;129(1):174-81
references.pmid: 16424429
references.citation: JAMA. 1994 Jan 5;271(1):59-63
references.pmid: 8258890
references.citation: Arch Intern Med. 2002 Aug 12-26;162(15):1682-8
references.pmid: 12153370
references.citation: Am J Prev Med. 2008 Mar;34(3):216-23
references.pmid: 18312810
references.citation: JAMA. 1993 Dec 1;270(21):2598-601
references.pmid: 8230645
references.citation: PLoS Negl Trop Dis. 2009 Jun 30;3(6):e473
references.pmid: 19564904
references.citation: PLoS Clin Trials. 2006 May;1(1):e9
references.pmid: 16871331
references.citation: Psychiatr Serv. 2005 Oct;56(10):1261-8
references.pmid: 16215192
references.citation: Health Promot Int. 2004 Jun;19(2):235-45
references.pmid: 15128715
references.citation: Lancet. 2011 Jan 1;377(9759):52-62
references.pmid: 21176950
references.citation: J Am Geriatr Soc. 1997 Aug;45(8):923-8
references.pmid: 9256842
references.citation: BMJ. 2003 Aug 9;327(7410):320-1
references.pmid: 12907485
references.citation: Br J Cancer. 2002 Sep 9;87(6):615-20
references.pmid: 12237770
references.citation: Lancet. 2006 May 6;367(9521):1521-32
references.pmid: 16679166
references.citation: Health Technol Assess. 2005 Oct;9(38):iii-iv, ix-x, 1-152
references.pmid: 16181564
references.citation: Clin Trials. 2007;4(1):42-57
references.pmid: 17327245
references.citation: Clin Infect Dis. 2010 Feb 15;50(4):531-40
references.pmid: 20067426
references.citation: J Clin Epidemiol. 2005 Feb;58(2):130-7
references.pmid: 15680745
references.citation: JAMA. 2007 Mar 21;297(11):1233-40
references.pmid: 17374817
references.citation: Eval Health Prof. 2006 Mar;29(1):126-53
references.pmid: 16510882
references.citation: Age Ageing. 1995 Nov;24(6):461-3
references.pmid: 8588532
references.citation: BMJ. 2006 Aug 12;333(7563):346-9
references.pmid: 16902217
references.citation: PLoS Med. 2005 May;2(5):e107
references.pmid: 15916456
references.citation: Acta Oncol. 2002;41(2):131-7
references.pmid: 12102156
references.citation: BMJ. 2003 Oct 4;327(7418):763-4
references.pmid: 14525851
references.citation: Crit Care. 2006;10(5):232
references.pmid: 17029653
references.citation: BMJ. 2004 Jun 19;328(7454):1490
references.pmid: 15205295
references.citation: JAMA. 2001 Aug 8;286(6):708-13
references.pmid: 11495621
references.citation: Ann Intern Med. 2010 Jun 1;152(11):726-32
references.pmid: 20335313
references.citation: J Clin Psychopharmacol. 2005 Jun;25(3):271-5
references.pmid: 15876909
references.citation: PLoS One. 2012;7(12):e50325
references.pmid: 23236367